Zhengbin Yao insider trades

Open-market stock purchases and sales by Zhengbin Yao, President and CEO at ArriVent BioPharma, Inc, from SEC Form 4 filings since Mar 2, 2020.

Recent trades

DateStockTradeValue
Feb 2, 2026AVBP ArriVent BioPharma, IncBought (not open market)—

Companies traded

  • AVBP ArriVent BioPharma, Inc: other filings, last Feb 2, 2026
  • ALMS Alumis Inc: other filings, last Jul 30, 2025
  • NEXI NexImmune, Inc: other filings, last Jul 5, 2023
  • VIE Viela Bio, Inc: other filings, last Mar 15, 2021

Get free alerts when Zhengbin Yao files a new trade →